| Jessica Patricia Mantilla, MD | |
|
435 Arden Ave, Suite 350, Glendale, CA 91203-1130 | |
| (818) 500-0935 | |
| Not Available |
| Full Name | Jessica Patricia Mantilla |
|---|---|
| Gender | Female |
| Speciality | Infectious Disease |
| Experience | 16 Years |
| Location | 435 Arden Ave, Glendale, California |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1891957973 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207RI0200X | Internal Medicine - Infectious Disease | A110850 (California) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| San Gabriel Valley Medical Center | San gabriel, CA | Hospital |
| Garfield Medical Center | Monterey park, CA | Hospital |
| Alhambra Hospital Medical Center | Alhambra, CA | Hospital |
| Monterey Park Hospital | Monterey park, CA | Hospital |
| Entity Name | Jessica Mantilla Md Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1861841348 PECOS PAC ID: 0941595094 Enrollment ID: O20160829000970 |
News Archive
Cellular Dynamics International (CDI) and VivoMedica plc announce the launch of CARDIOTOX - a pharmaceutical industry consortium to validate a human cell model and analysis system for preclinical cardiotoxicity testing of pharmaceutical candidate compounds.
A landmark study in mice identifies a biological mechanism that could help explain how tobacco products could act as gateway drugs, increasing a person's future likelihood of abusing cocaine and perhaps other drugs as well, according to the National Institute on Drug Abuse (NIDA), part of the National Institutes of Health. The study is the first to show that nicotine might prime the brain to enhance the behavioral effects of cocaine.
Researchers of the Max Delbr-ck Center for Molecular Medicine (MDC) Berlin-Buch have now identified and described a molecular mechanism underlying the most common malformation of the brain in humans. In holoprosencephaly (HPE), the forebrain (prosencephalon) is only incompletely formed.
Researchers in Israel have conducted a study exploring the behavioral and psychological impact of the coronavirus disease 19 (COVID-19) pandemic in an effort to understand the biological and environmental factors that may influence how individuals cope with the crisis.
› Verified 2 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Jessica Patricia Mantilla, MD 435 Arden Ave, Suite 350, Glendale, CA 91203-1130 Ph: (818) 500-0935 | Jessica Patricia Mantilla, MD 435 Arden Ave, Suite 350, Glendale, CA 91203-1130 Ph: (818) 500-0935 |
News Archive
Cellular Dynamics International (CDI) and VivoMedica plc announce the launch of CARDIOTOX - a pharmaceutical industry consortium to validate a human cell model and analysis system for preclinical cardiotoxicity testing of pharmaceutical candidate compounds.
A landmark study in mice identifies a biological mechanism that could help explain how tobacco products could act as gateway drugs, increasing a person's future likelihood of abusing cocaine and perhaps other drugs as well, according to the National Institute on Drug Abuse (NIDA), part of the National Institutes of Health. The study is the first to show that nicotine might prime the brain to enhance the behavioral effects of cocaine.
Researchers of the Max Delbr-ck Center for Molecular Medicine (MDC) Berlin-Buch have now identified and described a molecular mechanism underlying the most common malformation of the brain in humans. In holoprosencephaly (HPE), the forebrain (prosencephalon) is only incompletely formed.
Researchers in Israel have conducted a study exploring the behavioral and psychological impact of the coronavirus disease 19 (COVID-19) pandemic in an effort to understand the biological and environmental factors that may influence how individuals cope with the crisis.
› Verified 2 days ago
Tigran Khachatryan, Infectious Disease Medicare: Accepting Medicare Assignments Practice Location: 660 W Broadway, Glendale, CA 91204 Phone: 818-243-9600 | |
Dr. Jean-pierre E Antaki, M.D. Infectious Disease Medicare: Accepting Medicare Assignments Practice Location: 801 S Chevy Chase Dr, #105, Glendale, CA 91205 Phone: 818-242-5299 Fax: 818-637-7607 | |
Dr. Ellie Bloomfield, M.D. Infectious Disease Medicare: Not Enrolled in Medicare Practice Location: 1808 Verdugo Blvd, Suite 403, Glendale, CA 91208 Phone: 818-790-7098 Fax: 818-790-7099 | |
Edgar H Aleman, MD Infectious Disease Medicare: Accepting Medicare Assignments Practice Location: 435 Arden Ave, 410, Glendale, CA 91203 Phone: 818-242-4191 Fax: 818-242-4811 | |
Michael Eugene Klein, MD Infectious Disease Medicare: Accepting Medicare Assignments Practice Location: 1818 Verdugo Blvd, #300, Glendale, CA 91208 Phone: 818-952-5332 Fax: 818-790-6830 | |
Alen Mirzaian, M.D. Infectious Disease Medicare: May Accept Medicare Assignments Practice Location: 1818 Verdugo Blvd Ste 401, Glendale, CA 91208 Phone: 818-790-1145 | |
Dr. Thomas Yarger Pocock, MD Infectious Disease Medicare: Not Enrolled in Medicare Practice Location: 1809 Verdugo Blvd, #200, Glendale, CA 91208 Phone: 818-790-6700 Fax: 818-790-2816 |